Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.
Gallbladder carcinoma and carcinoma of the bile ducts are relatively rare cancers in the United States. These cancers are often diagnosed in an advanced stage due to their nonspecific symptomatology and until recently have been associated with a dismal prognosis. Recent advances in imaging and surgical techniques along with emerging options in palliative chemotherapy have improved the outlook in these cancers. While complete surgical resection remains the only hope of cure in both these cancers, palliative biliary decompression and chemotherapy result in substantial improvement in quality of life. Part 1 of this review, which appeared in last month's issue, provided a relevant and comprehensive update of molecular pathology, imaging modalities, and surgical care. In part 2, we examine palliative care and systemic therapy in gallbladder and biliary tract carcinomas, as well as the use of liver transplantation in the treatment of cholangiocarcinomas. These strategies are of relevance to internists as well as oncologists caring for these patients.
Harvard University, Boston, Massachusetts, USA.
William P
WP
Daines
Vandana
V
Rajagopalan
Michael L
ML
Grossbard
Peter
P
Kozuch
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001661:Biliary Tract Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D002277:Carcinoma; D017024:Chemotherapy, Adjuvant; D018281:Cholangiocarcinoma / Q000628:therapy; D003131:Combined Modality Therapy; D019299:Decompression, Surgical; D005706:Gallbladder Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D006801:Humans; D016031:Liver Transplantation; D010166:Palliative Care; D011379:Prognosis; D011788:Quality of Life